Core Viewpoint - Galloper Gold Corp. has successfully closed a non-brokered private placement, raising $2,500,000 through the issuance of 41,666,667 units at a price of $0.06 per unit, which positions the company strongly for its 2026 exploration plans [1][3]. Group 1: Private Placement Details - The private placement involved the issuance of 41,666,667 units, each consisting of one common share and one common share purchase warrant, with warrants exercisable at $0.09 until February 9, 2029 [1][2]. - The total gross proceeds from the private placement amount to $2,500,000 [1]. - The company paid finders' fees totaling $31,184.85 to various financial institutions involved in the placement [4]. Group 2: Use of Proceeds - The net proceeds from the private placement will be utilized for the commencement of the company's 2026 exploration program and for general working capital purposes [6]. Group 3: Company Overview - Galloper Gold Corp. is focused on mineral exploration in the Central Newfoundland Gold Belt, with its flagship Glover Island Property located 24 km southeast of Corner Brook [8].

Group 1 - Critical Reagent Processing Corp. has closed a non-brokered private placement, issuing 3,500,000 common shares at $0.0675 per share, resulting in gross proceeds of $236,250 [1][2] - The company plans to use the net proceeds from the private placement for general working capital [2] - No finder's fees were paid in connection with the private placement, and the shares are subject to a statutory hold period of four months from the closing date [2] Group 2 - Critical Reagent Processing Corp. has completed a purchase option agreement to acquire up to a 100% interest in the Mina Laguna Santa Maria project, which includes two mining concessions for sodium carbonate production [3] - The project consists of 500 hectares with a natural deposit of sodium carbonate, which is essential for lithium carbonate production [3] - The U.S. Geological Survey reported that 165,000 tonnes of soda ash were exported from the U.S. to Argentina in 2022, valued at $48 million, indicating a significant market opportunity for the company [3]

Core Viewpoint - Falcon Energy Materials plc has announced a non-brokered private placement to raise gross proceeds of C$25,000,000, indicating strong shareholder confidence and support for the company's strategic direction and future projects [1][3]. Private Placement Details - The company will issue up to 41,666,667 units at a price of C$0.60 per unit, with each unit consisting of one ordinary share and one non-transferable share purchase warrant [2]. - Each warrant allows the holder to purchase an additional share at a price of C$0.75 for a period of 36 months from the closing date [2]. - Proceeds from the private placement will be allocated to the development of the Morocco Anode Plant and general working capital [3]. Shareholder Support - The private placement is backed by the company's largest shareholders, reflecting confidence in Falcon's strategy and long-term prospects [3]. - The company is also welcoming new high-profile shareholders with strong business relationships globally, which may enhance its market position [3]. Regulatory and Insider Participation - The private placement is subject to standard regulatory approvals, including those from the TSX Venture Exchange [3]. - Insider participation in the private placement is expected, although the extent has not yet been determined [4]. Company Overview - Falcon Energy Materials aims to be a leading provider of natural Coated Spheronized Purified Graphite, essential for energy storage solutions [6]. - The company is developing a state-of-the-art production facility in Morocco with a capacity of 25,000 tons per annum [6]. - Falcon has strategic partnerships with leading Chinese technology firms and Tier One Moroccan partners, enhancing its technological capabilities and access to quality raw materials [7].

Core Viewpoint - Lexicon Pharmaceuticals has successfully closed a public offering of 32 million shares of common stock and a concurrent private placement of 22.4 million shares of common stock and 367,145 shares of Series B Convertible Preferred Stock, with the offerings closing on February 2, 2026 [1]. Group 1: Offering Details - The public offering price for the common stock was set at $1.30 per share, while the Series B Convertible Preferred Stock was sold at $65 per share [1]. - An additional 30-day option has been granted to underwriters to purchase up to 4.8 million shares of common stock at the public offering price [2]. - The Private Placement Purchaser has the option to buy an additional 94,855 shares of Series B Convertible Preferred Stock, convertible into 4,742,744 shares of common stock, at the same price of $65 per share [2]. Group 2: Use of Proceeds - Lexicon intends to utilize the net proceeds from the offerings for the continued research and development of its drug candidates, as well as for working capital and other general corporate purposes [4]. Group 3: Regulatory Information - A shelf registration statement related to the public offering was filed with the SEC on August 2, 2024, and was declared effective on August 15, 2024 [5]. - The shares issued in the private placement have not been registered under the Securities Act and may not be offered or sold in the U.S. without proper registration or exemption [5]. Group 4: Company Overview - Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing medicines that transform patients' lives, with a pipeline targeting neuropathic pain, hypertrophic cardiomyopathy, obesity, metabolism, and other indications [7].

Core Viewpoint - Altura Energy Corp. has successfully closed an oversubscribed non-brokered private placement offering, raising gross proceeds of approximately $2.97 million through the issuance of 29,705,977 units at a price of $0.10 per unit [1]. Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrant allowing the purchase of one common share at an exercise price of $0.25 until February 5, 2031 [2]. - The company may accelerate the expiry date of the warrants if the closing price of the common shares reaches or exceeds $0.75 for twenty consecutive trading days [2]. Use of Proceeds - The net proceeds from the offering will be allocated for site maintenance, additional well recompletions, working capital, and general corporate purposes [4]. Finder's Fees - The company paid finder’s fees totaling $174,702 and issued 1,627,020 finder's warrants, which have the same terms as the warrants in the units [5]. Related Party Transaction - Mr. Ian Telfer, a director of the company, subscribed for 1,000,000 units for gross proceeds of $100,000, constituting a related party transaction [7]. Advisory Agreement - The company entered into a new strategic advisory services agreement with Haywood Securities Inc., agreeing to issue 2,900,000 units at a deemed price of $0.10 per unit for services rendered [8]. - The agreement includes a monthly consulting fee of $15,000, payable in common shares, subject to TSX Venture Exchange approval [9]. Company Overview - Altura Energy Corp. is an exploration and production company with interests in the Holbrook basin of Arizona [10].

Core Viewpoint - Zephyr Minerals Ltd. has successfully closed a non-brokered private placement, raising $260,000 through the issuance of 5,200,000 units, which will be utilized for various project-related activities and general working capital [1][2]. Group 1: Private Placement Details - The private placement consists of units, each comprising one common share and one common share purchase warrant, with warrants priced at $0.10 for a period of 24 months [1]. - The company paid finders' fees of $9,450 in cash and issued 189,000 finders' warrants, which also allow the acquisition of shares under the same terms [3]. - Insiders acquired 900,000 units for $45,000, qualifying as a related party transaction, and the company relied on exemptions from formal valuation and minority shareholder approval requirements [4]. Group 2: Dawson Gold Project Information - The Dawson Gold Deposit has an inferred mineral resource of 343,000 tonnes grading 12.11 g/t, equating to 133,500 ounces of gold at a 5 g/t cut-off [5]. - A Preliminary Economic Assessment (PEA) indicated robust economics with an all-in sustaining cost of $692 per ounce, based on a gold price of $1,250/oz [5]. - The project has significant exploration potential, particularly at depth and along the 700-meter-long Sentinel zone, which remains untested [5]. Group 3: Company Overview - Zephyr Minerals is focused on obtaining a mining permit for its 100% owned Dawson Gold property in Colorado and is awaiting the Zimbabwean Government's decision on two Exclusive Prospecting Orders [6]. - The company has not updated the resource estimate to include results from drilling programs conducted between 2017 and 2020, which may enhance the attractiveness of the Dawson project given the increase in gold prices [5][6].

Core Viewpoint - Inspira Technologies has announced a registered direct offering of 6,785,715 ordinary shares at a price of $0.70 per share, expected to raise approximately $4.75 million before expenses [1][2]. Group 1: Offering Details - The offering is set to close on or about February 6, 2026, pending customary closing conditions [2]. - The net proceeds from the offering will be utilized for working capital and general corporate purposes [2]. - A.G.P./Alliance Global Partners is acting as the sole placement agent for this offering [2]. Group 2: Securities and Registration - The ordinary shares are being offered under a prospectus supplement to be filed with the SEC, linked to the Company's effective shelf registration statement [3]. - The warrants issued in a concurrent private placement will have an exercise price of $0.70 per share and will be exercisable six months after issuance, expiring in 5.5 years [1][3]. Group 3: Existing Warrants Amendment - Existing warrants issued to the investor in December 2023, originally priced at $1.28, will be amended to a reduced exercise price of $0.70 per share, expiring five years from the closing date [5]. Group 4: Company Overview - Inspira Technologies specializes in advanced respiratory support and real-time blood monitoring solutions, with FDA-cleared products including the INSPIRA™ ART100 system [6]. - The company is developing the INSPIRA ART500 system for oxygenation while patients remain awake and is advancing the HYLA™ blood sensor platform for continuous, non-invasive monitoring [6]. - With a growing IP portfolio and strategic operational streamlining, Inspira Technologies is positioned as an attractive player in the life-support and MedTech sectors [6].

Core Viewpoint - LB Pharmaceuticals Inc has entered into a securities purchase agreement to raise approximately $100 million through a private placement of common stock and pre-funded warrants, aimed at funding clinical trials and general corporate purposes [1][3]. Group 1: Financing Details - The company will sell 3,306,571 shares of common stock at a price of $21.17 per share and pre-funded warrants to purchase up to 1,417,107 shares at $21.1699 each [1]. - The private placement is expected to close on or about February 6, 2026, pending customary closing conditions [1]. Group 2: Investor Participation - The financing includes participation from both new and existing institutional investors, such as Balyasny Asset Management L.P., Caligan Partners, and others [2]. - Placement agents for the private placement include Leerink Partners, Piper Sandler, and Stifel [2]. Group 3: Use of Proceeds - The net proceeds from the private placement will be used to fund a Phase 2 trial for LB-102 as an adjunctive treatment for major depressive disorder, along with working capital and general corporate purposes [3]. Group 4: Company Overview - LB Pharmaceuticals is a late-stage biopharmaceutical company focused on developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases [6]. - The company is advancing its lead product candidate, LB-102, which aims to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the U.S. [6].

Core Viewpoint - Desert Gold Ventures Inc. has increased its non-brokered private placement offering due to strong investor demand, raising the total gross proceeds from C$5,000,000 to C$7,230,000 [1][2]. Group 1: Offering Details - The offering will now consist of up to 90,375,000 Offered Units, each comprising one Common Share and one-half of a Warrant, with the Warrant allowing the purchase of one Common Share at C$0.12 within 24 months after the closing date [2]. - The closing of the offering is expected on February 9, 2026, subject to necessary approvals, including from the TSX Venture Exchange [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated to the first phase of the gravity plant at the Barani East gold oxide project in West Mali, resource expansion and exploration drilling at the SMSZ Project in Western Mali, exploration drilling at the Tiegba Gold Project in Cote d'Ivoire, and general working capital [3]. Group 3: Regulatory Compliance - The Offered Units will be available for sale to purchasers in all Canadian provinces except Québec, under the Listed Issuer Financing Exemption, and will also be offered in the United States and other jurisdictions in compliance with applicable laws [4]. Group 4: Finder's Fees - The company may pay finders a cash commission of up to 7.0% of the gross proceeds from subscribers they introduce, along with finders warrants equal to 7.0% of the Offered Units introduced [6]. Group 5: Company Overview - Desert Gold Ventures is a gold exploration company with properties in Mali and Cote d'Ivoire, including the 440 km² SMSZ Project in Western Mali and the 297 km² Tiegba Gold Project in Cote d'Ivoire [8].

Core Viewpoint - Metalite Resources Inc. is increasing its non-brokered private placement due to strong investor demand, raising total gross proceeds from $465,000 to $700,000 [1] Private Placement Details - The private placement will consist of units priced at $0.15 each, with each unit comprising one common share and one-half of a common share purchase warrant [4] - The warrants will allow holders to purchase one common share at a price of $0.25, with an expiry date two years from issuance, subject to acceleration if the share price exceeds $0.50 for ten consecutive trading days [4] Debt Settlement - Concurrently, the company plans to settle $352,842 of debt by issuing 2,352,277 common shares at a deemed price of $0.15 per share [2] - The debt settlement is part of a strategy to manage obligations to senior management and advisors [2] Closing Timeline - The private placement and debt settlement are expected to close around February 9, 2026 [3] Use of Proceeds - The net proceeds from the private placement will be utilized for working capital and general corporate purposes [6] Shareholder Approval - Due to the issuance exceeding 100% of the currently outstanding common shares, shareholder approval is required before the issuance of certain shares and warrants [6] - The company intends to obtain this approval through written consent from a majority of shareholders [6] Insider Participation - Certain insiders are expected to participate in the private placement, which is classified as a related party transaction [7] - The company will rely on exemptions from formal valuation and minority approval requirements, as the participation does not exceed 25% of the company's market capitalization [7] Company Overview - Metalite Resources Inc. is a Canadian junior mineral exploration issuer focused on precious metals projects in New South Wales, Australia [8]